Treatment is complex and options are limited
Mitral regurgitation (MR) occurs in approximately 2% of the population, with up to 10% of people over 75 years old affected1
Empowering delivery system with direct manoeuvring in 3 planes
Independent leaflet capture
Designed for effective MR
Broad paddles maximize leaflet coaptation
Central spacer fills the regurgitant orifice area
Spacer & contoured paddle design reduce stress on leaflets
Implant elongation helps promote safe subvalvular manoeuvring
For professional use
For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions, and adverse events.
Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.
Material for distribution only in countries with applicable health authority product registrations. Material not intended for distribution in USA or Japan.
Edwards, Edwards Lifesciences, the stylized E logo, PASCAL, and Cardioband are trademarks of Edwards Lifesciences .Corporation or its affiliates. All other trademarks are the property of their respective owners.